✓. Accept the obligation not to receive any other facial procedures or treatments anywhere in the face during the study that are not related to the study.
✓. Women of childbearing potential must have a negative urine pregnancy test before each injectable treatment and practice a reliable method of contraception throughout the study.
✓. Ability to follow study instructions and likely to complete all required visits and assessments, as assessed by the Investigator.
Exclusion criteria
✕. Females who are pregnant, nursing, or planning a pregnancy.
✕. Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
✕. Subject in a social or sanitary establishment (socially or mentally vulnerable).
✕
What they're measuring
1
Forehead Contouring: Proportion of subjects with a Global Aesthetic Improvement Scale (GAIS) equal to 'improved" or "much improved" as assessed by a blinded aesthetic doctor of the contouring of the forehead using a 3D image.
Timeframe: Baseline to 30 Days
2
Marionette Lines: Proportion of subjects with a ≥1-point change in the Marionette Line scale from baseline before treatment to 30 days post treatment.
. Current enrolment in an investigational drug or device study, participation in such a study within 6 weeks before enrollment, or be planning to participate in another investigation during the course of this study.
✕. Is an employee (or immediate relative of an employee) of the Investigator, study staff, Allergan, or a representative of Allergan.
✕. In France: subject having received 4500 euros indemnities for participation in researches involving human beings in the 12 previous months, including participation in the present study.
✕. Has a history of multiple or severe allergies, anaphylaxis, atopy, or allergy to lidocaine, HA products, or Streptococcal protein, or is planning to undergo desensitization therapy during the study.
✕. Has an active inflammation or infection (acne, herpes,…), cancerous or precancerous lesion, or unhealed wound.